79
Views
6
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH ARTICLES

Dermaseptin S4 derivative K4K20S4: A potential candidate for development of a new microbicide contraceptive agent – an in vitro study

, &
Pages 79-87 | Published online: 08 Mar 2013
 

ABSTRACT

Background and objectives Sexually transmitted infections (STIs) and unplanned pregnancies have serious effects on the reproductive health of women. The present study was undertaken with a view to develop an effective means of prevention. The microbicidal and contraceptive potential of cationic peptides from frog's skin, namely, dermaseptin S4 and its derivatives were investigated in vitro.

Study design Different bacterial and fungal strains were resorted to for determining the antimicrobial activity of the new compounds. The spermicidal activities of the latter were assessed using normal human semen samples, and their toxic effects were identified in a HeLa culture.

Results All S4 derivatives elicited concentration-dependent spermicidal and antimicrobial activities at microgram concentrations. The highest levels recorded for both types of activity were displayed by K4K20S4, and the lowest levels were exhibited by D4D20S4 and S4(5–28). Cytotoxicity assays revealed that some of these compounds were significantly safer than nonoxynol-9 (N-9).

Conclusions The ability of these peptides to instantaneously kill human sperm and STI pathogens at low concentrations indicates that their application as active ingredients in vaginal contraceptive preparations could induce considerably better effects than N-9.

ACKNOWLEDGEMENTS

The authors express their sincere gratitude to Mr Anouar Smaoui and Mrs Hanen Ben Salem from the English Language Unit at the Sfax Faculty of Science for the linguistic assistance they kindly provided.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and the writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.